Skip to content

The feasibility study of transcranial magnetic stimulation for resistant major depressive episode

The feasibility study of transcranial magnetic stimulation for resistant major depressive episode - The feasibility study of transcranial magnetic stimulation for resistant major depressive episode

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000013553
Enrollment
20
Registered
2014-04-01
Start date
2014-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

major depressive disorder, bipolar disorder

Interventions

Low-frequency rTMS to the right dorsolateral prefrontal cortex or High-frequency rTMS to the left dorsolateral prefrontal cortex

Sponsors

Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Science
Lead Sponsor
Okayama Psychiatric Medical Center
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)DSM-IV-TR diagnosis of major depressive disorder (MDD) or bipolar disorder (BD) 2)Hamilton Scale for Depression 17-item score: 14 or more 3)Medication resistance(Insufficient clinical improvement of MDD from at least two antidepressant trials/ Insufficient clinical improvement of BD from lithium or lamotrigine and atypical antipsychotic treatment ) 4)Capability of informed consent 5)Aged 20 years old or more

Exclusion criteria

Exclusion criteria: 1)Other Axis I disorders 2)Axis II disorders 3)Seizure-inducing disease (brain tumor, head injury, etc.) 4)Neurologic disorder, organic brain disorder 5)History of seizure 6)Paroxysmal EEG abnormality 7)Pregnancy 8)Ferromagnetic material in head(except oral cavity) 9)Patients with a pacemaker 10)Active suicide idea 11)Stupor state 12)Previous treatment with electroconvulsive therapy within one month 13)Depressive patients related to physical diseases or drugs 14)Family members of researchers 15)Patients likely to change to another hospital within 6 months 16)Patients judged to be not appropriate for participation in this study by the physician 17) Patients who do not understand Japanese

Design outcomes

Primary

MeasureTime frame
Adherence to treatment

Secondary

MeasureTime frame
1)Beck Depression Inventry II(BDI-II) 2)Hamilton Depression Rating Scale (Ham-D) 17items 3)Montgomery Asberg Depression Scale (MADRS) 4)Frequency,Intensity, and Burden of Side Effects Rating (FIBSER) 5)Young Manic Rating Scale (YMRS)

Countries

Japan

Contacts

Public ContactMasatoshi Inagaki

Okayama University Hospital Department of Neuropsychiatry

masatoshiinagaki@med.okayama-u.ac.jp086-235-7246

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026